7545-24-6

Basic information

• Product Name: N,N-bis(2-hydroxyethyl)hexadecan-1-amide
• Synonyms: N,N-bis(2-hydroxyethyl)hexadecan-1-amide;PALMITAMIDE DEA;N,N-Bis(2-hydroxyethyl)hexadecan-1-amid;n,n-bis(2-hydroxyethyl)-hexadecanamid;N,N-bis(2-hydroxyethyl)-Hexadecanamide;palmitic acid diethanolamide;N,N-Bis(2-hydroxyethyl)palmitamide;N,N-Bis(2-hydroxyethyl)palmitic amide
• CAS NO: 7545-24-6
• Molecular Formula: C₂₀H₄₁NO₃
• Molecular Weight: 343.54444
• EINECS: 231-427-2
• Mol File: 7545-24-6.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: N,N-bis(2-hydroxyethyl)hexadecan-1-amide(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-bis(2-hydroxyethyl)hexadecan-1-amide(7545-24-6)
• EPA Substance Registry System: N,N-bis(2-hydroxyethyl)hexadecan-1-amide(7545-24-6)

Safety Data

• Hazardous Substances Data: 7545-24-6(Hazardous Substances Data)

Usage

General Description

N,N-bis(2-hydroxyethyl)hexadecan-1-amide is a chemical compound commonly used as a surfactant, fabric softener, and viscosity control agent in various consumer products, including cosmetics, personal care products, and household cleaners. It is a type of fatty acid amide, with the hydroxyl groups providing its surfactant properties while the long hydrophobic carbon chain makes it a useful emollient and conditioning agent for skin and hair. This chemical is also known by the trade name Ethomeen C/25 and is considered safe for use in cosmetics and personal care products when used in accordance with industry guidelines and regulations.

InChI:InChI=1/C20H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(24)21(16-18-22)17-19-23/h22-23H,2-19H2,1H3

Upstream product

• 111-42-2 2,2'-iminobis[ethanol] 
• 57-10-3 1-hexadecylcarboxylic acid 
• 112-67-4 n-hexadecanoyl chloride 
• 112-39-0 hexadecanoic acid methyl ester 

Downstream Products

• 111-42-2 2,2'-iminobis[ethanol] 
• 57-10-3 1-hexadecylcarboxylic acid 

Relevant articles and documents

Methods for production of fatty acid alkanolamides (FAAAs) from microalgae biomass

Provided herein are methods for fatty acid alkanolamide (FAAA) synthesis and isolation from lipid-containing algal biomass, and the products of such methods.

Oil soluble molybdenum amine complex and preparation method thereof

The invention discloses an oil soluble molybdenum amine complex and a preparation method of the oil soluble molybdenum amine complex. The method adopts long-chain saturated fatty acid as the starting material, acylchlorination reaction is carried out on the long-chain saturated fatty acid and thionyl chloride to obtain 1-chloro saturated fatty acid, then amidation reaction is carried out on the 1-chloro saturated fatty acid and diethanol amine to obtain saturated fatty acid amide, and finally complexation is carried out on the saturated fatty acid amide and a molybdenum trioxide solution so as to obtain the oil soluble molybdenum amine complex. The prepared molybdenum amine complex has good oil solubility, solves the poor oil solubility, corrosion resistance, wear resistance and friction reduction and other problems difficult to overcome in existing products, at the same time significantly reduces the adding amount of high sulfur and phosphorus components, and has enormous boosting effect on organic molybdenum series lubricating products currently under research in China, thus promoting nationalization of high-end lubricating oil and efficient utilization and high added value of molybdenum resources.

N-palmitoylethanolamide derivatives: Synthesis and studies on anticonvulsant and antidepressant activities

A series novel of N-palmitoylethanolamide derivatives was synthesized and screened for their anticonvulsant and antidepressant activities. Anticonvulsant activities and neurotoxicities of compounds when injected intraperitoneally (i.p.) were determined by maximal electroshock seizure (MES) test and a rotarod test, respectively, in mice. Only four of the synthesized compounds (3a, 3b, 3c, and 3d) showed anticonvulsant activity at a dose of 100 mg/kg. Six compounds showed reduced immobility durations during the forced swimming test at a dose of 10 mg/kg, indicative of antidepressant activity. Among the compounds, N-(3-hydroxypropyl)cinnamamide (3a) was the most promising compound and significantly reduced the duration of immobility duration by 23.36% at a dose of 10 mg/kg compared with the control (P0.01). Springer Science+Business Media, LLC 2010.